{"name":"Minerva Biotechnologies Corporation","slug":"minerva-biotechnologies-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5jeEI2TjJTbVNuY180TUQ5N2hGeGQ1Y1IwZjM5bmt4N01tOXJuN1BnMGc5Zm5mMk1BeXYycnQ5VVJ2dk5yZ3VhUlBpXzZKVVBTcVFVVWU4aTFBQUhYcW13dEg5OGU4VGk0NENMX2FR?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Minerva Neurosci (NERV) - Stock Titan","headline":"If You Invested $1,000 in Minerva Neurosci (NERV)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-16","type":"pipeline","source":"simplywall.st","summary":"Minerva Neurosciences, Inc.'s (NASDAQ:NERV) market cap touched US$271m last week, benefiting both retail investors who own 55% as well as institutions - simplywall.st","headline":"Minerva Neurosciences, Inc.'s (NASDAQ:NERV) market cap touched US$271m last week, benefiting both retail investors who o","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywJBVV95cUxNTDdsVHNSaFpBNmwxVkNpM05sT19NaDF6eVRtLTJScnFWd2h1NnpCbTJZX3lfRk5KZk5QTGQ4VzZjYkxwd2ZidDVDRjBTLWZ4cEg5RTFzV3RUNFdZN3BZeTVybm9fZFJtZXRyMkU1cHR3R2RESlhWbEFjNXNBM1QwTEhNX0ticU1RS2hhMjYyeWF1dnR3cUYxMDJmZWFGR01HSUpRUUo5alFHY1N5S0YzRFNlR0RNNmtEd1FpZHQzMVNmd09PcDJHRGIwSVhFQ01SUmNZTzlpa1pXdlBuZ21YY1VtbTdOOXN5RlFWR0h6NEJRZkMycHVKcktRdlYtS2E1ZElxYzA4NEFGV2hsTDRORkFhODZ4ck50S3BJREZKai01ZzU5amxQY0F2VklGYm1uTEhSTFlCa1FpSlhoMnR5NHhnSVZRckVNZmg0?oc=5","date":"2025-10-21","type":"trial","source":"Investing News Network","summary":"Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and R","headline":"Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Sy","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQc0hJWHZBR0h2UF9ScXoyakFOMGhpbDBZQlJoODdqc25pdVFDM1M3UlFPQV9PM3B4R1ZtNjdiZVYxZW02YnQwUVpPZUF0R3JTY19Lamh6ZC1kd0Yxekt2OG9OakhFeEh5Vm16NzQzVHVieXVIZ3dHM1Z5UzZVZmM3MHhHekZWbUNncjdwNzI3aVZoQVFxd2c?oc=5","date":"2025-08-28","type":"pipeline","source":"Seeking Alpha","summary":"LB Pharmaceuticals Launches $100 Million IPO Effort (Pending:LBRX) - Seeking Alpha","headline":"LB Pharmaceuticals Launches $100 Million IPO Effort (Pending:LBRX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQTXFBSkY3amloMjBmR0lFUGZKOXpYcFVGOWZtdl9XSUx0alVZOXJfWmtVS1F3S3FPSUw5Y05tSEJrZHJUMlpBeDdkNXlJWk16ejNjUmIwby1sSzBuay1UZ0xuNzMtWHNwN1o2RkQyOEVWX2dQdjVHbGpBOG5KWjZCR2FSQXRKZXd0?oc=5","date":"2025-08-08","type":"pipeline","source":"NEREJ","summary":"Minerva Biotechnologies signs 13,000 s/f lease at Cummings Park - NEREJ","headline":"Minerva Biotechnologies signs 13,000 s/f lease at Cummings Park","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxNdGJiX1hIRnBfajZ4OUVpTXN3X1RHTUNnT1RLdUFOSGlGbHN5NjVnbll1a1h4UEVpNjNHcURnUF9xb1pVM2pwX2JVVFlnWHh6SU9LOFh3U0Zwd1FXZmxpVXpvbHZtcGRhTU14YmxudmF3azRzckJlYUpvZ2dlN2NJbTFPYkdIaTFLVHhOTTZBZWRSNlB5LTQ5UnJOeHlGeUpaVTkwNERUYi02blpuUHhPdjhBZ3p6NTRLTlNLdFZ5Slh6YVlCblhXTGdzYjNEMHMwY0ZwZDV0MDBoU3p5V1RQTnpHb1I1NUJmTGotckNWZzQwSFdTVUdYaFc4S29yWWc5Q1pnTTZib1VxLTRHSmUzbUprc0c1OEdpN2JtZzd1MUxLMm1SNDhjMERR?oc=5","date":"2025-07-07","type":"trial","source":"GlobeNewswire","summary":"Bispecific Antibody Clinical Trial Pipeline Gains Momentum: - GlobeNewswire","headline":"Bispecific Antibody Clinical Trial Pipeline Gains Momentum:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxQV1JBcWNmYk85cFJyVU9PYzE1c0x3b2RjcW9fN1JUQ1FNc1BRUjNMRkltMTl3cHZCdnpoOHFvQlFCY3BrQ0ZWa1lxQnNCb055NlZyVlcwelZGd1hxRmhCVnBybXdSS1B3eFJZT1JUV0JfWGFEM2Vvc3ZJNzdRdUlPcmR4YkJjSEEyWGhIYm0xZkk0cXJLTzNXeXR3anY5cjA4eEQwbzNVWjUtSWxDdm55Ti0zWFh3TW8zUnlRcmpVTFhQc0NCMmJydTdVUzBYbXdGbGR5R2xPeWNLX3VuV0t6bWduNW1GYnhSYl8zbmFfa2lteDBGTzNtQUlKNHlOczZjYXFISHdpc3dtUm9IY0FCNmQwZ2hPeEhYdTAwaFFwTXlGd2Z4NHdpbUxiZXU1dGM5UjBrVjQ2UTc5QlJkM0NyUVlQWnBQTkU?oc=5","date":"2025-03-05","type":"trial","source":"GlobeNewswire","summary":"CAR T-cell Therapy Clinical Trial Pipeline Experiences - GlobeNewswire","headline":"CAR T-cell Therapy Clinical Trial Pipeline Experiences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOQnBiZ3lCWnNWZVZqTWp6NkJaTk5zVkNkSUgtbTctd0ZwZzJGcUFlWk9QWlBzdExPeWM3OWl3ZGM0TGFUbWlpTkR2c0JzQUtiRUdTOER3LXFlcFZNeUY2WXo5ZlVCQy1qWUtpRl84NU9JNFE2UzRKcnpmaVZVUVJSQlRwbUZWRlVqMWNEcXN4YW82UQ?oc=5","date":"2024-09-17","type":"pipeline","source":"Contract Pharma","summary":"MinervaX, Wacker Biotech Enter GBS Vax Pact - Contract Pharma","headline":"MinervaX, Wacker Biotech Enter GBS Vax Pact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE83U3ViVWNqRUVOaS0tNGdsblRxcHZSWHd4Si10SFI1VFRfMFVrVUViOS1icFB3NmdBUXg2VnBOcE1WeWQyTTVfeE9WV0hlbmNXcHJnUnV4RGxVcmxWR1V4THFDVnFWeW1Ec2VOWDVsdGxRdngtSlNnNA?oc=5","date":"2024-05-31","type":"pipeline","source":"labiotech.eu","summary":"Biotech career fairs in the U.S. you don’t want to miss - labiotech.eu","headline":"Biotech career fairs in the U.S. you don’t want to miss","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPYVd3d04wdEVjTDFuR3QtTTNZMV9ycWhMZ2pCNTJweFpQVWVRRWxRQUlVWjJtZmFyTnMzTGhRQmItMk5oS194ck1aWktIbEl6bUNnbFN4YzMzQnNlVjdvcERWQUh5alAxLVRCX2s5RmkzRFEwU3Q1allfaWpmUEgzNnpiTjBKY2dCX1p1SkVpN1lZRzNKODJtODZudjlIYU9DN1B1UVB3?oc=5","date":"2024-02-27","type":"regulatory","source":"BioPharma Dive","summary":"Minerva schizophrenia drug rejected by FDA - BioPharma Dive","headline":"Minerva schizophrenia drug rejected by FDA","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNTWNNQjRvT1N6WU1jMGRJZGRGVXpXVmFBZVluS0ZrOUtleHQwajJfcFBlTVlGUGlKR0ZjTThkcUhYZEJqSC1vUU1WbUpPZ25neEp4MnRySzYycHg0U1BRN0FYWUdlSmV1all5dnZKV0xLamlQYm9vQ0JWRllSdkR4UlVlQWNwU2tjZGtYQjJJZXI2MnhSdkx3M1Bfay1TSUNaNHJyTjg4X2NOMXlMclVqam91VzRULS1SYWlaTUJjcjRWVmpzSnc?oc=5","date":"2023-01-09","type":"pipeline","source":"Fierce Biotech","summary":"Women's health drugmaker Organon places bet on hysterectomy hardware developer Claria Medical - Fierce Biotech","headline":"Women's health drugmaker Organon places bet on hysterectomy hardware developer Claria Medical","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}